Redhill expands manufacturing for COVID-19 candidate
Company signs deals with two specialist pharmaceutical manufacturers
Read More
Tag: Redhill Biopharma
MHRA issues consent for RedHill Bioharma’s Yeliva trial
The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
